PTC
IMPV

Philadelphia Trust Company’s Imperva, Inc. IMPV Stock Holding History

Philadelphia Trust Company’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-58,750
Closed -$2.41M – 228
2017
Q1 		$2.41M Buy
+58,750
New +$2.45M 0.2% 86

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Philadelphia Trust Company's IMPV Position: Q2 2017 in Review

Philadelphia Trust Company sold out of Imperva, Inc. (IMPV) in Q2 2017, closing a stake of 58,750 shares — an estimated $2.41M sold.

Philadelphia Trust Company first reported a position in IMPV in Q1 2017 and held it in 1 quarter. The position peaked at $2.41M in Q1 2017. 181 funds tracked by Wall St. Rank hold IMPV as of Q2 2017.

  • Philadelphia Trust Company reported no remaining Imperva, Inc. position as of Q2 2017 after selling out during the quarter.
  • Philadelphia Trust Company sold 58,750 Imperva, Inc. shares in Q2 2017, an estimated $2.41M.
  • Philadelphia Trust Company first reported a position in Imperva, Inc. in Q1 2017 and held it in 1 quarter.
  • Philadelphia Trust Company's Imperva, Inc. position peaked at $2.41M in Q1 2017.
  • 181 funds tracked by Wall St. Rank held Imperva, Inc. as of Q2 2017.

Based on Philadelphia Trust Company's 13F filing for Q2 2017, filed 14 Aug 2017.